Version July 2025
| Disorder | |
| Infection | HIV, cytomegalovirus, parvovirus B19, Epstein-Barr virus, severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), pulmonary tuberculosis, leishmaniasis, malaria |
| Autoimmune | Adult Still's disease, systemic lupus erythematosus, mixed connective tissue disorder |
| Malignancy | Hemophagocytic lymphohistiocytosis, multiple myeloma, acute monoblastic leukemia |
| Acute glomerular ischemia | Thrombotic microangiopathy, renal infarction, atheroembolism, hydrophilic polymer embolism |
| Genetic | APOL1 high-risk alleles, sickle cell disease, mitochondrial disorders (coenzyme Q deficiency), acute myoclonus-renal failure syndrome, Galloway-Mowat syndrome |
| Drug exposure | Bisphosphonates, interferons (alpha, beta, or gamma), anabolic steroids, calcineurin inhibitors, mTOR inhibitors |
| Superimposed on other glomerular diseases | IgA nephropathy, diabetic glomerulopathy |
| Posttransplantation (de novo) | Arteriopathy/thrombotic microangiopathy, acute rejection, viral infection (cytomegalovirus, Epstein-Barr virus, BK polyomavirus) |
